IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
109.05%
Total 13F principal
$114,312,000
Principal change
+$2,050,000
Total reported market value
$134,119,152
Number of holders
20
Value change
+$2,268,648
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q3 2021

As of 30 Sep 2021, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $114,312,000 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, HBK INVESTMENTS L P, DeepCurrents Investment Group LLC, CSS LLC/IL, LAZARD ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., BNP PARIBAS ARBITRAGE, SA, Verition Fund Management LLC, and JPMORGAN CHASE & CO. This page lists 20 institutional bondholders reporting positions for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.